IDEXX Laboratories recently reported third-quarter 2025 earnings per share of $3.40, up over one-fifth year over year and ahead of expectations, while raising its full-year 2025 guidance for both ...

Westbrook, Maine-based IDEXX Laboratories, Inc. (IDXX) is a global leader in veterinary diagnostics and animal-health ...

IDEXX Laboratories is a global company that provides products and services for primarily companion animals. Revenue has grown at a rate of 10%, driven by improving market conditions and an expansion ...

A month has gone by since the last earnings report for Idexx Laboratories (IDXX). Shares have added about 1.5% in that time frame, outperforming the S&P 500. But investors have to be wondering, will ...

Idexx Laboratories has steadily increased its scale and reach in the veterinary diagnostic lab business to dig a narrow moat. It is well-positioned to benefit from two key trends. First, pet ownership ...

Wall Street analysts expect Idexx Laboratories (IDXX) to post quarterly earnings of $3.14 per share in its upcoming report, which indicates a year-over-year increase of 12.1%. Revenues are expected to ...

IDEXX Laboratories, Inc. IDXX is set to release second quarter 2023 results on Aug 1 before the opening bell. The company posted adjusted earnings per share (EPS) of $2.55 in the last reported quarter ...

IDEXX Laboratories, Inc. is a U.S. healthcare company, that currently leads the veterinary industry developing diagnostics tools to satisfy veterinarians’ everyday needs. IDEXX has delivered solid and ...

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2025 first quarter financial results for Thursday, May 1, 2025, before the ...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital.' So it might ...